Showing results (431-440 of 1,383) with videos related to

Sort By:
Pageof 139
ACS Pharmacology & Translational Science|May 20, 2022
Craft of Co-encapsulation in Nanomedicine: A Struggle To Achieve Synergy through ReciprocitySourav Bhattacharjee
ACS Pharmacology & Translational Science|May 20, 2022
Rapamycin in Cerebral Cavernous Malformations: What Doses to Test in Mice and HumansMatthew J Hagan, Robert Shenkar, Abhinav Srinath, et al.
ACS Pharmacology & Translational Science|May 20, 2022
Efficacy and Selectivity of Monovalent and Bivalent Vaccination Strategies to Protect against Exposure to Carfentanil, Fentanyl, and Their Mixtures in RatsBethany Crouse, Mariah M Wu, Valeria Gradinati, et al.
ACS Pharmacology & Translational Science|May 20, 2022
Prolyl Hydroxylase Domain Protein Inhibitor Not Harboring a 2-Oxoglutarate Scaffold Protects against Hypoxic StressKento Sonoda, Sudarma Bogahawatta, Akito Katayama, et al.
ACS Pharmacology & Translational Science|July 5, 2022
Correction to "Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study"Herana Kamal Seneviratne, Allyson N Hamlin, Sue Li, et al.
ACS Pharmacology & Translational Science|June 15, 2022
Different Aspects of Emetine's Capabilities as a Highly Potent SARS-CoV-2 Inhibitor against COVID-19Mehdi Valipour
ACS Pharmacology & Translational Science|June 17, 2022
Evaluation of Antioxidant Therapeutic Value of ACE Inhibitor as Adjunct Therapy on Type 2 Diabetes Mellitus Patients with Cardiovascular DiseaseAbdulsalam Elfowiris, Ali Banigesh
ACS Pharmacology & Translational Science|December 17, 2020
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease InhibitorsChunlong Ma, Yanmei Hu, Julia Alma Townsend, et al.
ACS Pharmacology & Translational Science|February 11, 2020
Identification of Pirin as a Molecular Target of the CCG-1423/CCG-203971 Series of Antifibrotic and Antimetastatic CompoundsErika M Lisabeth, Dylan Kahl, Indiwari Gopallawa, et al.
ACS Pharmacology & Translational Science|June 17, 2021
Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19Xin Hu, Jonathan H Shrimp, Hui Guo, et al.
Pageof 139